Previous reports examining genotype–phenotype relationships in patients with acromegaly showed that patients with GNAS mutations (GNAS-MT) presented with smaller tumors and had better SSA responsiveness than those without GNAS-MT11,12, although the relationships between other gene mutations and clinical features remain unclear. The gene discussed is GNAS; the disease is acromegaly.